• Information

    The launch of a new immunity ingredient

    07 August 2017
    Ganeden has used its patented probiotic strain to develop an immune health ingredient: Staimune. The new ingredient utilizes the cells of the probiotic GanedenBC30 to support immune health, at cost effective inclusion levels. Ganeden anticipates Staimune to be an industry changing development. Officially identified as “Inactivated Bacillus coagulans GBI-30, 6086,” Staimune’s ease of formulation opens up new opportunities in functional foods and beverages – most importantly in shelf-stable beverages and high-water-activity products. 

Related Content

Ganeden, Inc.

Collapse

Founded in 1997, Ohio-based Ganeden is at the forefront of probiotic research and product development with an extensive library of published studies and more than 130 patents for probiotic technologies for the supplement, food, beverage, animal health, sports nutrition and personal care ingredients markets. Ganeden is best known for GanedenBC30® its patented, FDA GRAS, highly stable probiotic ingredient. Through the fermentation process of GanedenBC30®, Ganeden developed Bonicel®, the first science-backed, probiotic-derived, personal care ingredient shown to dramatically reduce signs of aging. Ganeden’s newest ingredient, Staimune™ is patented probiotic technology comprising of inactivated GanedenBC30® which has been shown to have immune benefits.  Ganeden is more than an ingredient supplier; Ganeden works with its clients as a partner, taking special care to add value from initial contact to product launch and beyond. For more information about Ganeden and licensing opportunities visit GanedenProbiotics.com.

Introducing GanedenBC30® (Bacillus coagulans GBI-30, 6086), Ganeden’s patented probiotic ingredient that can be found in more than 750 leading food, beverage, sports nutrition and companion animal products around the world. Unlike most other probiotic strains, GanedenBC30® is a spore-former which makes it highly stable and allows it to remain viable through most manufacturing processes, three years of shelf life and the low pH of stomach acid.  The benefits, safety and efficacy of GanedenBC30® is backed by over 20 published studies and FDA GRAS status from the United States FDA. It can be formulated into virtually any food, beverage, sports nutrition or companion animal product that is baked, boiled, frozen or squeezed…. including all hot or refrigerated beverages!  For more information, please visit GanedenBC30.com.

Articles On NutritionInsight

Collapse

Business News 18 August 2017

DuPont expands US probiotics pilot facility to improve NPD, delivery times

18 Aug 2017 --- DuPont Nutrition & Health (DuPont) has announced a “substantial upgrade” to its probiotics pilot facility in Madison, Wisconsin, US. The new enhancements will increase its capability for rapidly developing and commercializing new probiotics with decreased time to market. The US$10 million investment allows for increased pace of new product development and significantly improved delivery times on pilot material for clinical trials and customer evaluations, according to DuPont.

Food Ingredients News 17 August 2017

Ganeden’s Health Canada approvals assist company’s expansion in Canada

17 Aug 2017 --- Ganeden has made advancements for the usage of its probiotic strain GanedenBC30 in Canada. The probiotic ingredient company has received a no objection letter from national public health department Health Canada, which provides further support for approved probiotic wording and allows Canadian companies fortifying with GanedenBC30 to make additional health claims.

Business News 09 June 2017

Key Interview: Ganeden Looks for Probiotic Opportunities Beyond Digestive Health

09 Jun 2017 --- Consumers increasingly self-diagnose and experiment with diets that they believe will improve gut health. These personalized diets are creating new opportunities for free from and fortification. Innova Market Insights has reported +25% CAGR from 2012 to 2016 for food & beverage launches with a digestive health positioning, with probiotics benefiting. In fact there was a +30% CAGR in new products featuring the word “probiotic” during this period, despite the term currently not being allowed in EU markets.

More Articles

Video Interviews

Collapse

01 August 2013

article image Michael Bush, Ganeden Biotech

Michael Bush of Ganeden Biotech on New Applications for Probiotics.